UPCDC-10205

N/A

Report date: 2025/01/26 17:53:07
NME

Base Information

Drug NameUPCDC-10205
Drug Alias NameUPCDC-10205
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionIL-6 metabolism modulators
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Pittsburgh
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A